| Literature DB >> 30505171 |
Mohammad Attaullah1, Masarrat J Yousuf2, Sohail Shaukat3, Syed Ishtiaq Anjum4, Mohammad Javed Ansari5,6, Islam Dad Buneri2, Muhammad Tahir2, Muhammad Amin2, Naveed Ahmad7, Shahid Ullah Khan8.
Abstract
Organochlorine pesticides (OCPs) are frequently used worldwide as insecticides, fungicides, herbicides and termiticides and have been associated with a variety of cancers in animal and human studies. In the present study, we examined residues of fourteen OCPs in the serum samples of diagnosed cancer patients and healthy residents of Karachi, Pakistan. A random collection of fasting blood samples was carried out from the donors with informed consent. Serum was separated within 2 h of blood collection and was then subjected to extraction with organic solvents followed by purification with florisil column. The final organic extract of each serum sample was processed with Gas Chromatograph coupled with Electron Capture Detector (GC-ECD). OCPs were detected in 97.59% of the cancer cases and 93.75% of the healthy subjects. Mean concentrations of total OCPs (ΣOCPs) was found elevated in the cancer group (0.606 mg/kg) compared with the control group (0.322 mg/kg). Endosulfan was the highest prevalent OCP with a mean concentration of 0.214 mg/kg in the cancer group and 0.166 mg/kg in the control group. The second most prevalent OCP was 4,4-DDE with a mean concentration of 0.131 mg/kg in the cancer group and 0.019 mg/kg in the control group. Highest level of ΣOCPs was detected in the breast cancer cases (20.411 mg/kg) with a mean level of (2.041 mg/kg). In light of the obtained results and available literature on the subject, it has been concluded that OCPs are positively associated with the risk of various cancers in humans.Entities:
Keywords: Cancer; DDE; Endosulfan; GC-ECD; Organochlorine pesticides; Serum
Year: 2017 PMID: 30505171 PMCID: PMC6252000 DOI: 10.1016/j.sjbs.2017.10.023
Source DB: PubMed Journal: Saudi J Biol Sci ISSN: 2213-7106 Impact factor: 4.219
Comparison of total OCPs in the age groups of cancer cases and controls.
| Type of samples | Age statistics | ΣOCPs | |||
|---|---|---|---|---|---|
| Age groups (Yrs) | Mean age (Yrs) | ΣΧ (mg/kg) | Mean (mg/kg) | SD | |
| Cancer cases | 15–28 | 19.8 | 4.988 | 0.226 | 0.369 |
| 29–42 | 35.6 | 6.907 | 0.246 | 0.6 | |
| 43–56 | 47.7 | 25.823 | 1.359 | 3.121 | |
| 57–70 | 63.6 | 12.355 | 1.123 | 2.307 | |
| 71–84 | 76.3 | 0.215 | 0.071 | 0.024 | |
| Mean Total | 39.5 | 50.288 | 0.606 | 1.789 | |
| Controls | 15–28 | 22 | 4.815 | 0.283 | 0.339 |
| 29–42 | 33.5 | 4.055 | 0.506 | 0.379 | |
| 43–56 | 47.3 | 0.536 | 0.178 | 0.193 | |
| 57–70 | 62 | 0.343 | 0.171 | 0.016 | |
| 71–84 | 79 | 0.557 | 0.278 | 0.352 | |
| Mean Total | 33.2 | 10.306 | 0.322 | 0.334 | |
Frequencies of the individual OCPs detected in the cancer cases and controls.
| S. no | Name of OCP | Frequency (%) in the cancer cases | Frequency (%) in the controls |
|---|---|---|---|
| 1 | α-HCH | 39.75 | 34.337 |
| 2 | β-HCH | 34.93 | 21.87 |
| 3 | γ-HCH | 18.07 | 31.25 |
| 4 | δ- HCH | 20.48 | 21.87 |
| 5 | Heptachlor | 55.42 | 31.25 |
| 6 | Hepta exo-epoxide | 31.32 | 46.87 |
| 7 | Hepta endo-epoxide | 15.66 | 12.5 |
| 8 | Endosulfan | 77.1 | 78.12 |
| 9 | Aldrin | 16.88 | 25 |
| 10 | Dieldrin + Endrin | 37.34 | 34.37 |
| 11 | 4,4-DDD | 25.3 | 9.37 |
| 12 | 4,4-DDE | 14.45 | 28.12 |
| 13 | 4,4-DDT | 4.81 | 6.25 |
| 14 | Methoxychlor | 12.04 | 12.5 |
| Total | ΣOCPs | 97.59 | 93.75 |
Fig. 5Frequencies of the studied OCPs in the cancer cases and controls.
Detected mean levels of the studied OCPs in the cancer cases and controls.
| S. no. | Name of OCP | Cancer cases | Controls | ||||
|---|---|---|---|---|---|---|---|
| ΣΧ (mg/kg) | Mean (mg/kg) | SD | ΣΧ (mg/kg) | Mean (mg/kg) | SD | ||
| 1 | α-HCH | 1.179 | 0.014 | 0.046 | 0.069 | 0.002 | 0.006 |
| 2 | β-HCH | 1.228 | 0.014 | 0.042 | 0.098 | 0.003 | 0.007 |
| 3 | γ-HCH | 0.256 | 0.003 | 0.014 | 0.056 | 0.001 | 0.004 |
| 4 | δ- HCH | 2.505 | 0.03 | 0.206 | 0.086 | 0.002 | 0.008 |
| 5 | Heptachlor | 4.436 | 0.053 | 0.159 | 1.608 | 0.05 | 0.124 |
| 6 | Hepta-exo-epoxide | 0.86 | 0.01 | 0.026 | 0.255 | 0.007 | 0.014 |
| 7 | Hepta-endo-epoxide | 1.302 | 0.015 | 0.113 | 0.276 | 0.008 | 0.027 |
| 8 | Endosulfan | 17.797 | 0.214 | 0.901 | 5.32 | 0.166 | 0.21 |
| 9 | Aldrin | 1.311 | 0.016 | 0.071 | 0.052 | 0.001 | 0.003 |
| 10 | Dieldrin + Endrin | 2.979 | 0.035 | 0.211 | 0.677 | 0.021 | 0.043 |
| 11 | 4,4-DDD | 1.741 | 0.02 | 0.102 | 0.075 | 0.002 | 0.009 |
| 12 | 4,4-DDE | 10.937 | 0.131 | 1.112 | 0.639 | 0.019 | 0.055 |
| 13 | 4,4-DDT | 2.377 | 0.028 | 0.2 | 0.801 | 0.025 | 0.135 |
| 14 | Methoxychlor | 1.375 | 0.016 | 0.071 | 0.292 | 0.009 | 0.026 |
| Total | ΣOCPs | 50.27 | 0.606 | 1.789 | 10.307 | 0.322 | 0.334 |
OCP: Organochlorine pesticides; ΣΧ: Sum of the detected pesticides; SD: Standard deviation.
Fig. 2Mean levels of total OCPs in the age groups of the cancer cases and controls.
Fig. 4Mean values of the individual OCPs in the studied major cancer sites.
Concentrations of total OCPs (ΣOCPs) in the studied cancer sites.
| Major cancer site | Sub site | ΣOCPs | ||
|---|---|---|---|---|
| ΣΧ (mg/kg) | Mean (mg/kg) | SD | ||
| Oral cavity & pharynx | Tongue | 0.139 | 0.046 | 0.053 |
| Pharynx | 0.23 | 0.23 | 0 | |
| Mean total | 0.369 | 0.092 | 0.101 | |
| Digestive system | Esophagus | 10.237 | 1.462 | 2.72 |
| Stomach | 0.04 | 0.02 | 0.021 | |
| Colon | 1.305 | 0.217 | 0.236 | |
| Rectum | 0.665 | 0.166 | 0.07 | |
| Bile Duct | 2.602 | 1.301 | 1.059 | |
| Pancreas | 0.333 | 0.166 | 0.038 | |
| Appendix | 1.245 | 0.622 | 0.808 | |
| Mean total | 16.427 | 0.657 | 1.517 | |
| Respiratory system | Larynx | 2.867 | 0.573 | 0.767 |
| Lung | 0.262 | 0.087 | 0.068 | |
| Mean total | 3.129 | 0.391 | 0.633 | |
| Breast | Breast | 20.411 | 2.041 | 4.286 |
| Skin | Neck | 0.641 | 0.16 | 0.249 |
| Cheek | 0.517 | 0.103 | 0.139 | |
| Abdomen | 0.04 | 0.04 | 0 | |
| Mean Total | 1.198 | 0.119 | 0.176 | |
| Female genital system | Cervix | 0.566 | 0.188 | 0.165 |
| Ovary | 0.026 | 0.026 | 0 | |
| Vagina | 0.024 | 0.024 | 0 | |
| Mean Total | 0.617 | 0.123 | 0.146 | |
| Blood | ALL | 0.061 | 0.015 | 0.012 |
| AML | 4.801 | 0.436 | 0.962 | |
| CML | 0.323 | 0.161 | 0.016 | |
| Mean total | 5.185 | 0.305 | 0.783 | |
| Lymphatic system | HL | 1.205 | 0.602 | 0.604 |
| NHL | 1.741 | 0.87 | 1.115 | |
| Mean Total | 2.946 | 0.736 | 0.748 | |
Fig. 3Mean levels of total OCPs in the major sites and sub sites of cancer cases.
Mean levels of individual OCPs in the analyzed major cancer sites.
| S. no. | Name of OCP | Major cancer sites with mean concentrations of OCPs (mg/kg) | |||||||
|---|---|---|---|---|---|---|---|---|---|
| Oral cavity, pharynx | Digestive system | Respiratory system | Breast | Skin | Female genital system | Blood | Lymphatic system | ||
| 1 | α-HCH | 0.003 | 0.011 | 0.024 | 0.035 | 0.003 | 0.0007 | 0.004 | 0.059 |
| 2 | β-HCH | 0.01 | 0.017 | 0.029 | 0.002 | 0.004 | 0.002 | 0.017 | 0.036 |
| 3 | γ-HCH | 0 | 0.004 | 0.013 | 0.0002 | 0.002 | 0 | 0.001 | 0 |
| 4 | δ- HCH | 0 | 0.081 | 0.0005 | 0.015 | 0.001 | 0.006 | 0.01 | 0.025 |
| 5 | Heptachlor | 0.013 | 0.083 | 0.003 | 0.079 | 0.011 | 0.057 | 0.029 | 0.143 |
| 6 | Heptaexoepoxide | 0.009 | 0.009 | 0.006 | 0.001 | 0.001 | 0.018 | 0.02 | 0.019 |
| 7 | Heptendoepoxide | 0 | 0.007 | 0.004 | 0.107 | 0.001 | 0.002 | 0 | 0 |
| 8 | Endosulfan | 0.012 | 0.315 | 0.072 | 0.537 | 0.011 | 0.017 | 0.169 | 0.207 |
| 9 | Aldrin | 0.039 | 0.003 | 0.006 | 0.004 | 0.051 | 0 | 0.003 | 0.1 |
| 10 | Dieldrin + Endrin | 0.002 | 0.009 | 0.007 | 0.241 | 0.003 | 0.019 | 0.006 | 0.01 |
| 11 | 4,4-DDD | 0 | 0.048 | 0.002 | 0.001 | 0.005 | 0 | 0.027 | 0 |
| 12 | 4,4-DDE | 0 | 0.014 | 0.001 | 1.017 | 0 | 0 | 0.017 | 0.027 |
| 13 | 4,4-DDT | 0 | 0.024 | 0.022 | 0 | 0 | 0 | 0 | 0 |
| 14 | Methoxychlore | 0 | 0.026 | 0.005 | 0 | 0.022 | 0 | 0 | 0.11 |
Fig. 1Mean levels of individual OCPs in the cancer cases and controls.